Q2 2023 Holdings
Filed 2023-08-14 | 101 holdings | $899.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $53.6M | 242,735 | 6.0% |
| Edap TMS S A(EDA) | SPONSORED ADR | 268311107 | $50.5M | 5,474,222 | 5.6% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $44.0M | 209,496 | 4.9% |
| Surmodics Inc(SU6) | COM | 868873100 | $41.9M | 1,336,838 | 4.7% |
| Organogenesis Hldgs Inc(ORGO) | COM | 68621F102 | $38.9M | 11,728,063 | 4.3% |
| Iradimed Corp(IRMD) | COM | 46266A109 | $36.9M | 773,694 | 4.1% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $32.0M | 4,250,000 | 3.6% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $31.7M | 1,001,999 | 3.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $28.5M | 571,250 | 3.2% |
| Humana Inc(HUM) | COM | 444859102 | $28.1M | 62,750 | 3.1% |
| CVS Health Corp(CVS) | COM | 126650100 | $24.5M | 355,054 | 2.7% |
| Celcuity Inc(CELC) | COM | 15102K100 | $21.1M | 1,923,283 | 2.3% |
| The Beauty Health Company(SKIN) | COM CL A | 88331L108 | $20.8M | 2,481,789 | 2.3% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $18.3M | 14,178,015 | 2.0% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $16.9M | 626,144 | 1.9% |
| Axogen Inc(AXGN) | COM | 05463X106 | $16.3M | 1,789,998 | 1.8% |
| Smith & Nephew PLC(SNN) | SPDN ADR NEW | 83175M205 | $15.8M | 489,268 | 1.8% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $13.7M | 71,000 | 1.5% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $13.0M | 4,321,197 | 1.4% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $12.9M | 110,192 | 1.4% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $12.3M | 473,183 | 1.4% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $11.3M | 4,202,094 | 1.3% |
| Neuropace Inc(NPCE) | COM | 641288105 | $11.1M | 2,466,214 | 1.2% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $10.8M | 435,500 | 1.2% |
| Jasper Therapeutics Inc | COM | 471871103 | $10.7M | 7,775,980 | 1.2% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $10.5M | 411,800 | 1.2% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $10.2M | 245,100 | 1.1% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $9.9M | 97,547 | 1.1% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $9.8M | 2,045,983 | 1.1% |
| Bausch Health COS Inc(BHC) | COM | 071734107 | $9.2M | 1,155,500 | 1.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $9.0M | 213,000 | 1.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $8.7M | 1,239,777 | 1.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $8.6M | 45,900 | 1.0% |
| Natera Inc(NTRA) | COM | 632307104 | $8.2M | 168,800 | 0.9% |
| Angiodynamics Inc(ANGO) | COM | 03475V101 | $8.0M | 768,500 | 0.9% |
| Theratechnologies Inc | COM | 88338H100 | $7.8M | 9,325,511 | 0.9% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $7.4M | 2,692,020 | 0.8% |
| Evolus Inc(EOLS) | COM | 30052C107 | $7.4M | 1,017,000 | 0.8% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $7.3M | 519,640 | 0.8% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $6.5M | 69,500 | 0.7% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $6.3M | 364,000 | 0.7% |
| Transmedics Group Inc(TMDX) | COM | 89377M109 | $6.2M | 74,200 | 0.7% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $6.1M | 194,400 | 0.7% |
| Pharvaris N V(PHVS) | COM | N69605108 | $5.9M | 391,900 | 0.7% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $5.9M | 1,776,897 | 0.7% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $5.5M | 336,700 | 0.6% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $5.4M | 2,054,105 | 0.6% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $5.1M | 307,000 | 0.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $5.0M | 57,800 | 0.6% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $4.6M | 176,000 | 0.5% |